{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:27:54Z","timestamp":1773185274881,"version":"3.50.1"},"reference-count":67,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Chronic myeloid leukemia (CML) is associated with the Philadelphia chromosome and distinct BCR::ABL1 gene transcripts. We assessed the frequencies of these transcripts in Mexico, Latin America, and worldwide. We determined the prevalence of BCR::ABL1 transcripts in CML patients and intercontinental or regional variations using specialized databases and keywords. We analyzed 34 studies from 20 countries, encompassing 5795 patients. Keyword-based searches in specialized databases guided data collection. ANOVA was employed for transcript distribution analysis. The b3a2 transcript was most prevalent globally, followed by b2a2, with e1a2 being the least frequent. Interestingly, Mexico City exhibited a higher incidence of b2a2, while b3a2 predominated in the remaining country. Overall, no significant intercontinental or regional variations were observed. b3a2 was the most common BCR::ABL1 transcript worldwide, with b2a2 following closely; e1a2 was infrequent. Notably, this trend remained consistent in Mexico. Evaluating transcript frequencies holds clinical relevance for CML management. Understanding the frequency of transcript informs personalized CML treatments.<\/jats:p>","DOI":"10.3390\/genes15020232","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T04:47:45Z","timestamp":1707713265000},"page":"232","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-1231","authenticated-orcid":false,"given":"Pablo","family":"Romero-Morelos","sequence":"first","affiliation":[{"name":"Department of Research, State University of the Valley of Ecatepec, Ecatepec 55210, Mexico State, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gonz\u00e1lez-Yebra","sequence":"additional","affiliation":[{"name":"Department of Applied Sciences to Work, Division of Health Sciences, University of Guanajuato, Campus Le\u00f3n, Le\u00f3n 37320, Guanajuato, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mu\u00f1oz-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Medicine and Nutrition, Division of Health Sciences, University of Guanajuato, Campus Le\u00f3n, Le\u00f3n 37320, Guanajuato, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Lara-Lona","sequence":"additional","affiliation":[{"name":"Department of Medicine and Nutrition, Division of Health Sciences, University of Guanajuato, Campus Le\u00f3n, Le\u00f3n 37320, Guanajuato, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-5860","authenticated-orcid":false,"given":"Beatriz","family":"Gonz\u00e1lez-Yebra","sequence":"additional","affiliation":[{"name":"Department of Medicine and Nutrition, Division of Health Sciences, University of Guanajuato, Campus Le\u00f3n, Le\u00f3n 37320, Guanajuato, Mexico"},{"name":"Research Unit, Baj\u00edo Regional High Specialty Hospital, Le\u00f3n, Guanajuato, Blvd. Milenio, Col, San Carlos, Le\u00f3n 37544, Guanajuato, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10238-018-0518-1","article-title":"Molecular biology as a tool for the treatment of cancer","volume":"18","author":"Junior","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1349-7006.2012.02346.x","article-title":"Molecular biology of chronic myeloid leukemia","volume":"103","author":"Maru","year":"2012","journal-title":"Cancer Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"a034819","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and Etiology of Leukemia and Lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.24774","article-title":"The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib","volume":"92","author":"Castagnetti","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"35","author":"Kang","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10428199509049762","article-title":"Does the type of BCR\/ABL junction predict the survival of patients with ph1-positive chronic myeloid leukemia?","volume":"16","author":"Zaccaria","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clml.2017.06.009","article-title":"Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib","volume":"17","author":"Pagnano","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_8","unstructured":"Mitelman, F., Johansson, B., and Mertens, F. (2021, December 13). Mitelman Database Chromosome Aberrations and Gene Fusions in Cancer. Available online: https:\/\/mitelmandatabase.isb-cgc.org."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000065655","article-title":"Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid Leukaemia","volume":"108","author":"Barnes","year":"2002","journal-title":"Acta Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12032-012-0348-z","article-title":"Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia","volume":"30","author":"Bennour","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ejh.13238","article-title":"Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay","volume":"103","author":"Kjaer","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ejh.13282","article-title":"\u201cVariant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.\u201d Is dPCR the key?","volume":"103","author":"Bernardi","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1515\/med-2021-0309","article-title":"Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia","volume":"16","author":"Amin","year":"2021","journal-title":"Open Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-4608(01)00515-5","article-title":"BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador, South America","volume":"132","author":"Burgos","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_15","first-page":"243","article-title":"Estudio del Reordenamiento Molecular BCR-ABL en Pacientes Cubanos con Diagn\u00f3stico Presuntivo de Leucemia Mieloide Cr\u00f3nica","volume":"12","year":"2011","journal-title":"Rev. Hematol."},{"key":"ref_16","first-page":"703","article-title":"BCR\/ABL1 Transcripts in Healthy Individuals: A Comparative Analysis Between First-Degree Relatives of Patients with Chronic Myelogenous Leukemia and Subjects without Antecedents of the Disease","volume":"49","year":"2019","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bekker-M\u00e9ndez, V.C., Miranda-Peralta, E., N\u00fa\u00f1ez-Enr\u00edquez, J.C., Olarte-Carrillo, I., Guerra-Castillo, F.X., Pompa-Mera, E.N., Oca\u00f1a-Mondrag\u00f3n, A., Rangel-L\u00f3pez, A., Bern\u00e1ldez-R\u00edos, R., and Medina-Sanson, A. (2014). Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: A population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemia. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/210560"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Saldivar, M.L., Fajardo-Guti\u00e9rrez, A., Bern\u00e1ldez-R\u00edos, R., Mart\u00ednez-Avalos, A., Medina-Sanson, A., Espinosa-Hern\u00e1ndez, L., and Flores-Chapa, J. (2011). de D.; Amador-S\u00e1nchez, R.; Pe\u00f1aloza-Gonz\u00e1lez, J.G.; Alvarez-Rodr\u00edguez, F.J.; et al. Childhood acute leukemias are frequent in Mexico City: Descriptive epidemiology. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-355"},{"key":"ref_19","first-page":"167","article-title":"Acute leukemia frequency observed in a reference hospital","volume":"50","year":"2012","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2015-10-674242","article-title":"Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"ref_21","first-page":"850","article-title":"Heterogeneity of breakpoint cluster region-Abelson (BCR-ABL) rearrangement in patients with chronic myeloid leukemia","volume":"30","author":"Tabassum","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"ref_22","first-page":"247","article-title":"Frequency of BCR-ABL Fusion Transcripts in Iranian Patients with Chronic Myeloid Leukemia","volume":"11","author":"Yaghmaie","year":"2008","journal-title":"Arch Iran Med."},{"key":"ref_23","first-page":"8420853","article-title":"Frequency of BCR-ABL Transcript Types in Syrian CML Patients","volume":"2016","author":"Habbal","year":"2016","journal-title":"J. Oncol."},{"key":"ref_24","first-page":"65","article-title":"BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran","volume":"9","author":"Ayatollahi","year":"2018","journal-title":"Casp. J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.trsl.2006.07.002","article-title":"Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR","volume":"148","author":"Goh","year":"2006","journal-title":"Transl. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.leukres.2013.12.025","article-title":"BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome","volume":"38","author":"Elias","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/bjh.15453","article-title":"Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: Data from a single centre","volume":"182","author":"Qin","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12185-019-02768-x","article-title":"Low prevalence of the BCR\u2013ABL1 fusion gene in a normal population in southern Sarawak","volume":"111","author":"Kuan","year":"2020","journal-title":"Int. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S1516-84842008000400013","article-title":"Papel da P190 BCR-ABL como par\u00e2metro de reca\u00edda na leucemia miel\u00f3ide cr\u00f4nica P190 BCR-ABL role in myeloid chronic leukemia relapse","volume":"30","author":"Andrade","year":"2008","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ijlh.12616","article-title":"Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients","volume":"39","author":"Arun","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ejh.12597","article-title":"Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia","volume":"96","author":"Lin","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3324\/haematol.2009.009134","article-title":"Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript","volume":"94","author":"Lucas","year":"2009","journal-title":"Haematologica"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1002\/mgg3.809","article-title":"Association of BCR\/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients","volume":"7","author":"Khazaal","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10428194.2017.1320711","article-title":"Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy","volume":"59","author":"Lee","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3324\/haematol.2013.096537","article-title":"Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib","volume":"99","author":"Hanfstein","year":"2014","journal-title":"Haematologica"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-4608(97)00263-X","article-title":"Chronic Myeloid Leukemia with Thrombocythemic Onset May Be Associated with Different BCR\/ABL Variant Transcripts","volume":"101","author":"Emilia","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_37","first-page":"1748","article-title":"Detection of BCR-ABL fusion gene and its transcript variants in chronic myeloid leukaemia patients\u2014A multi-comparison study","volume":"70","author":"Javed","year":"2020","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_38","first-page":"221","article-title":"Types of BCR-ABL and their correlations with the blood count in chronic myeloid leukemia (CML) in Togo","volume":"30","author":"Padaro","year":"2018","journal-title":"Pan Afr. Med. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Vasconcelos, A.P., Azevedo, I.F., Melo, F.C.B.C., Neves, W.B., Azevedo, A.C.A.C., and Melo, R.A.M. (2017). BCR-ABL1 transcript types showed distinct laboratory characteristics in patients with chronic myeloid leukemia. Genet. Mol. Res., 16.","DOI":"10.4238\/gmr16029541"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S1415-47572010005000037","article-title":"Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients","volume":"33","author":"Osman","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/0019-509X.176741","article-title":"Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients","volume":"52","author":"Mir","year":"2015","journal-title":"Indian J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0971-6866.132758","article-title":"A comprehensive analysis of breakpoint cluster region-abelson fusion oncogene splice variants in chronic myeloid leukemia and their correlation with disease biology","volume":"20","author":"Iqbal","year":"2014","journal-title":"Indian J. Hum. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0959-8049(00)00128-3","article-title":"The possible influences of B2A2 and B3A2 BCR\/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia","volume":"36","author":"Perego","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"ref_44","first-page":"338","article-title":"Prevalence of the BCR\/ABL1 transcripts in Mexican patients with chronic myelogenous leukemia","volume":"59","year":"2007","journal-title":"Rev. Investig. Clin."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.17533\/udea.iatreia.15539","article-title":"Frecuencia de los Transcriptos p190BCR-ABL y p210BCR-ABL en una Poblaci\u00f3n Colombiana con Leucemia Mieloide Cr\u00f3nica (LMC) Usando RT-PCR Cualitativa","volume":"27","author":"Alberto","year":"2014","journal-title":"Iatreia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2257.2002.00413.x","article-title":"BCR\/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with Chronic Myeloid Leukaemia (CML)","volume":"24","author":"Garces","year":"2002","journal-title":"Clin. Lab. Haematol."},{"key":"ref_47","first-page":"553","article-title":"An\u00e1lisis del tipo de Transcrito BCR-ABL y su relaci\u00f3n con la Cuenta Plaquetaria en Pacientes Mexicanos con Leucemia Mieloide Cr\u00f3nica","volume":"138","author":"Marroquin","year":"2003","journal-title":"Gac. Med. Mex."},{"key":"ref_48","first-page":"193","article-title":"Relationship of the BCR gene breakpoint and the type of BCR\/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia","volume":"8","author":"Prejzner","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/sj.leu.2403157","article-title":"Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon \u03b1\/ARA-C","volume":"17","author":"Gattermann","year":"2003","journal-title":"Leukemia"},{"key":"ref_50","first-page":"422","article-title":"BCR-ABL Gene Transcripts in Venezuelan Patients with Chronic Myeloid Leukemia","volume":"27","author":"Urdaneta","year":"2015","journal-title":"Saber"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S1516-84842000000200005","article-title":"An\u00e1lise dos transcritos da transloca\u00e7\u00e3o t(9;22) em Leucemia Miel\u00f3ide Cr\u00f4nica Artigo Especial","volume":"22","author":"Barboza","year":"2000","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_52","first-page":"428","article-title":"Frecuencia de los transcriptos BCR-ABL en pacientes cubanos con leucemia mieloide cr\u00f3nica","volume":"28","year":"2012","journal-title":"Rev. Cuba. Hematol. Inmunol. Hemoter."},{"key":"ref_53","first-page":"13","article-title":"Frecuencia de Transcritos BCR\/ABL P210 En 272 Pacientes Con Leucemia Mieloide Cr\u00f3nica (LMC) En Bolivia","volume":"22","author":"Masias","year":"2016","journal-title":"Rev. Med. La. Paz."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4067\/S0717-95022003000300004","article-title":"Transcriptos de Fusi\u00f3n del gen BCR\/ABL en Pacientes con Leucemia Mieloide Cr\u00f3nica","volume":"21","author":"Artigas","year":"2003","journal-title":"Int. J. Morphol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.54495\/Rev.Cientifica.v22i1.117","article-title":"Determinaci\u00f3n de la frecuencia de los transcritos de fusi\u00f3n BCR-ABL (e1a2, b2a2 y b3a2) por RT-PCR en muestras de m\u00e9dula \u00f3sea procedentes de pacientes con leucemia mieloide cr\u00f3nica (LMC) y leucemia linfobl\u00e1stica aguda Tipo B (LLA-B)","volume":"22","author":"Morales","year":"2012","journal-title":"Rev. Cient\u00edfica"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1590\/S1415-47572014000200003","article-title":"Interethnic admixture and the evolution of Latin American populations","volume":"37","author":"Salzano","year":"2014","journal-title":"Genet. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/cncr.28531","article-title":"Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia","volume":"120","author":"Lim","year":"2014","journal-title":"Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2214-109X(13)70150-5","article-title":"Global migration and the changing distribution of sickle haemoglobin: A quantitative study of temporal trends between 1960 and 2000","volume":"2","author":"Piel","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2352-3026(17)30232-6","article-title":"Epidemiological patterns of leukaemia in 184 countries: A population-based study","volume":"5","author":"Ferlay","year":"2018","journal-title":"Lancet Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2500\/108854192778817022","article-title":"Genetic difference between Europeans and Indians: Tissue and blood types","volume":"13","author":"Gorodezky","year":"1992","journal-title":"Allergy Proc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1038\/s41467-021-26188-w","article-title":"The genomic landscape of Mexican Indigenous populations brings insights into the peopling of the Americas","volume":"12","author":"Baca","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41467-017-01194-z","article-title":"Demographic history and biologically relevant genetic variation of Native Mexicans inferred from whole-genome sequencing","volume":"8","author":"Carnevale","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1016\/j.ygeno.2020.06.034","article-title":"Recombination disequilibrium in ideal and natural populations","volume":"112","author":"Tan","year":"2020","journal-title":"Genomics"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Fujikura, K. (2016). Global Carrier Rates of Rare Inherited Disorders Using Population Exome Sequences. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155552"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0277-9536(98)00023-9","article-title":"\u201cRace\u201d, ethnicity and haemoglobin disorders","volume":"47","author":"Dyson","year":"1998","journal-title":"Soc. Sci. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/ijc.33114","article-title":"Profiling global cancer incidence and mortality by socioeconomic development","volume":"147","author":"Georges","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e2020062","DOI":"10.4084\/mjhid.2020.062","article-title":"Prognostic significance of transcript-type BCR-ABL1 in chronic myeloid leukemia","volume":"12","author":"Molica","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/2\/232\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:58:46Z","timestamp":1760104726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/2\/232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["genes15020232"],"URL":"https:\/\/doi.org\/10.3390\/genes15020232","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]}}}